FDA Food recall F-1481-2019
Immulox, UPC 1 82863 000064 6. Immune Balance Polypeptide Supplement with Naturally Occuring Bioactive Peptides. 5.07 oz (150 ml)
- FDA Food
- Class II
- terminated
- Published 2019-06-26
On 2019-06-26 the FDA classified a Class II recall of Immulox, UPC 1 82863 000064 6. Immune Balance Polypeptide Supplement with Naturally Occuring Bioactive Peptides. 5.07 oz (150 ml) by Aps Biogroup, citing the recall is being conducted as a result of elevated APC levels. Through additional testing, it was determined that the organism is Stenotrophomonas maltophilia.
Read the official FDA Food notice
| Agency | FDA Food |
|---|---|
| Recall number | F-1481-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-05-15 |
| Published | 2019-06-26 |
| Last updated | 2026-09-13 11:50 UTC |
| Company | Aps Biogroup |
| Distribution | US |
Product
Immulox, UPC 1 82863 000064 6. Immune Balance Polypeptide Supplement with Naturally Occuring Bioactive Peptides. 5.07 oz (150 ml)
Reason
The recall is being conducted as a result of elevated APC levels. Through additional testing, it was determined that the organism is Stenotrophomonas maltophilia.
Identifiers
| upc | 1828630000646 |
|---|---|
| code_info | Manufactured April 21, 2019. Lot 9068-2, Item # 4044, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-3, Item # 4691, Bulk #…Manufactured April 21, 2019. Lot 9068-2, Item # 4044, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-3, Item # 4691, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-4, Item # 4181, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-5, Item # 00064, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-6, Item # 00064, Bulk # UL-7, Exp. Date 04/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:50 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-1481-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.